← All companies
Axsome Therapeutics, Inc.
AXSM - CIK 0001579428
Market cap$13.13 B
Rank#799
SEC filings634
The table below shows Axsome Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $322.93M | $315.35M | $386.19M | $200.84M | $86.47M | $183.88M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $224.46M | $142.00M | $94.82M | $37.70M | - | - |
| Inventory | $27.94M | $15.73M | $15.13M | $4.32M | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.